Position in ALKS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$285,762
New position
Shares Held
5,454
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#288
of 421 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fifth Third Wealth Advisors LLC holds $4,635,391 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
37,680 | $2,707,684 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
3,414 | $575,395 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
13,882 | $481,288 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
14,103 | $347,074 | |
| 5 | ALKS |
Alkermes plc.
This page
|
5,454 | $285,762 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,147 | $238,188 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,762 | 5,454 | Shares | Sole | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||